Follow The Filings

BC Brunswick

Brunswick earnings company data as of 7:58 AM ET 10/23

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 29 Oct EPS 1.35 — —
Rev — — —

Insider trades

Open-market buys and sales by BC's executives, directors and 10% owners in the last 12 months, from their Form 4s

All BC insider trades
  • None no insider bought on the open market
  • $7M sold by 3 insiders outside a trading plan
  • $63K sold by 1 insider under 10b5-1 plans
  1. Nancy E Cooper Director
    Planned sale
    $16K 206 shares at $78.45 0.7% of stake
    Traded Aug 3 Filed Aug 3
  2. David M Foulkes CEO
    Sale
    $2.1M 25,853 shares at $83.12 8.8% of stake
    Traded May 26 Filed May 27
  3. Nancy E Cooper Director
    Planned sale
    $15K 194 shares at $79.36 0.7% of stake
    Traded May 1 Filed May 4
  4. Nancy E Cooper Director
    Planned sale
    $17K 192 shares at $87.64 0.7% of stake
    Traded Feb 19 Filed Feb 19
  5. Ryan M Gwillim CFO
    Sale
    $1.1M 12,785 shares at $87.23 28% of stake
    Traded Feb 17 Filed Feb 18
  6. Christopher F Dekker E.v.p. Gen Counsel & Secretary
    Sale
    $435K 4,981 shares at $87.38 11% of stake
    Traded Feb 6 Filed Feb 9
  7. David M Foulkes CEO
    Sale
    $3.3M 38,266 shares at $86.56 12% of stake
    Traded Feb 5 Filed Feb 6
  8. Nancy E Cooper Director
    Planned sale
    $15K 233 shares at $64.12 0.9% of stake
    Traded Nov 3, 2025 Filed Nov 3, 2025

Also filed in the last 12 months, not counted as buying or selling: 47 stock grants, 26 share withholdings for taxes, and 1 gift.

SEC filings

Recent issuer filings from EDGAR, 11 shown.

Filed Form Detail Links
8-K 5.02,9.01
SCHEDULE 13G/A —
10-Q
8-K 2.02,9.01
10-Q
8-K 2.02,9.01
SCHEDULE 13G —
SCHEDULE 13G —
SCHEDULE 13G/A —
DEF 14A
DEFA14A

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.